These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 31250339)

  • 21. Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development.
    Nowak N; Skupien J; Smiles AM; Yamanouchi M; Niewczas MA; Galecki AT; Duffin KL; Breyer MD; Pullen N; Bonventre JV; Krolewski AS
    Kidney Int; 2018 May; 93(5):1198-1206. PubMed ID: 29398132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced albuminuria with sarpogrelate is accompanied by a decrease in monocyte chemoattractant protein-1 levels in type 2 diabetes.
    Ogawa S; Mori T; Nako K; Ishizuka T; Ito S
    Clin J Am Soc Nephrol; 2008 Mar; 3(2):362-8. PubMed ID: 18235151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients.
    Kim SS; Song SH; Kim IJ; Kim WJ; Jeon YK; Kim BH; Kwak IS; Lee EK; Kim YK
    Diabetes Metab Res Rev; 2014 Nov; 30(8):736-41. PubMed ID: 24687388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Kidney injury molecules (KIM-1, MCP-1) and type IV collagen in the assessment of activity of antineutrophil cytoplasmic antibody-associated glomerulonephritis].
    Bulanov NM; Serova AG; Kuznetsova EI; Bulanova ML; Novikov PI; Kozlovskaya LV; Moiseev SV
    Ter Arkh; 2017; 89(6):48-55. PubMed ID: 28745689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin.
    Wu C; Wang Q; Lv C; Qin N; Lei S; Yuan Q; Wang G
    Diabetes Res Clin Pract; 2014 Nov; 106(2):343-50. PubMed ID: 25263500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations of urinary epidermal growth factor and monocyte chemotactic protein-1 with kidney involvement in patients with diabetic kidney disease.
    Wu L; Li XQ; Chang DY; Zhang H; Li JJ; Wu SL; Zhang LX; Chen M; Zhao MH
    Nephrol Dial Transplant; 2020 Feb; 35(2):291-297. PubMed ID: 30357416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients.
    Kim SS; Song SH; Kim IJ; Yang JY; Lee JG; Kwak IS; Kim YK
    Diabetes Res Clin Pract; 2012 Aug; 97(2):251-7. PubMed ID: 22440044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary monocyte chemoattractant protein-1 and hepcidin and early diabetic nephropathy lesions in type 1 diabetes mellitus.
    Fufaa GD; Weil EJ; Nelson RG; Hanson RL; Knowler WC; Rovin BH; Wu H; Klein JB; Mifflin TE; Feldman HI; Vasan RS; Kimmel PL; Kusek JW; Mauer M;
    Nephrol Dial Transplant; 2015 Apr; 30(4):599-606. PubMed ID: 25648911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Panel of novel urine biomarkers for incident microalbuminuria in people with type 2 diabetes mellitus.
    Yamashita S; Shinozaki T; Murata H; Matsuyama Y; Babazono T
    Diabet Med; 2020 Nov; 37(11):1910-1918. PubMed ID: 32096274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of rosuvastatin and colestimide on metabolic parameters and urinary monocyte chemoattractant protein-1 in type 2 diabetic patients with hyperlipidemia.
    Takebayashi K; Suetsugu M; Matsumoto S; Aso Y; Inukai T
    South Med J; 2009 Apr; 102(4):361-8. PubMed ID: 19279518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients.
    Takebayashi K; Matsumoto S; Aso Y; Inukai T
    J Diabetes Complications; 2006; 20(2):98-104. PubMed ID: 16504838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue expression of tubular injury markers is associated with renal function decline in diabetic nephropathy.
    Hwang S; Park J; Kim J; Jang HR; Kwon GY; Huh W; Kim YG; Kim DJ; Oh HY; Lee JE
    J Diabetes Complications; 2017 Dec; 31(12):1704-1709. PubMed ID: 29037450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tubulointerstitial Biomarkers for Diabetic Nephropathy.
    Satirapoj B
    J Diabetes Res; 2018; 2018():2852398. PubMed ID: 29577044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased urinary excretion of monocyte chemoattractant protein-1 in proteinuric renal diseases.
    Morii T; Fujita H; Narita T; Koshimura J; Shimotomai T; Fujishima H; Yoshioka N; Imai H; Kakei M; Ito S
    Ren Fail; 2003 May; 25(3):439-44. PubMed ID: 12803507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury.
    Chow F; Ozols E; Nikolic-Paterson DJ; Atkins RC; Tesch GH
    Kidney Int; 2004 Jan; 65(1):116-28. PubMed ID: 14675042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nuclear NF-κB p65 in peripheral blood mononuclear cells correlates with urinary MCP-1, RANTES and the severity of type 2 diabetic nephropathy.
    Yi B; Hu X; Zhang H; Huang J; Liu J; Hu J; Li W; Huang L
    PLoS One; 2014; 9(6):e99633. PubMed ID: 24936866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The levels of circulating and urinary monocyte chemoattractant protein-1 are associated with chronic renal injury in obese men.
    Fu CP; Lee IT; Sheu WH; Lee WJ; Liang KW; Lee WL; Lin SY
    Clin Chim Acta; 2012 Oct; 413(19-20):1647-51. PubMed ID: 22609259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intercellular adhesion molecule, plasma adiponectin and albuminuria in type 2 diabetic patients.
    Lenghel AR; Kacso IM; Bondor CI; Rusu C; Rahaian R; Gherman Caprioara M
    Diabetes Res Clin Pract; 2012 Jan; 95(1):55-61. PubMed ID: 21945031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The renal transcriptome of db/db mice identifies putative urinary biomarker proteins in patients with type 2 diabetes: a pilot study.
    Simonson MS; Tiktin M; Debanne SM; Rahman M; Berger B; Hricik D; Ismail-Beigi F
    Am J Physiol Renal Physiol; 2012 Apr; 302(7):F820-9. PubMed ID: 22205226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diabetic Nephropathy Can Be Treated with Calcium Dobesilate by Alleviating the Chronic Inflammatory State and Improving Endothelial Cell Function.
    Zhou Y; Qi C; Li S; Shao X; Mou S; Ni Z
    Cell Physiol Biochem; 2018; 51(3):1119-1133. PubMed ID: 30476916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.